Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?
The expanded partnership increases the number of Highmark health plan members eligible for enrollment in Lark Health's AI-driven health coaching programs aimed at managing and preventing chronic diseases.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Startups are turning to voice data as they try to develop tools to detect a wide range of diseases. One startup, Vocalis Health, is working with Mayo Clinic to identify voice-based biomarkers for pulmonary hypertension.
DarioHealth, a digital health company focused on patients with diabetes and hypertension, rolled out behavioral health coaching for its users.
Covid-19 has taken a particularly heavy toll on people with chronic conditions. We must make it easier for people to stay healthy at home by providing them with the information, supplies, and support they need delivered when and where they need it.
At Livongo, we have developed and rolled out a targeted coronavirus response effort to keep our Members healthy, informed, and supported through the duration of this pandemic.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The implant — designated a breakthrough device by the FDA — would treat patients with pulmonary arterial hypertension. The progressive disease leads to heart failure but is usually treated with medication.
Oschner will partner with mail-order health company Hims & Hers to screen patients for blood pressure or diabetes.
The PBM selected 15 programs to offer on its first digital health formulary, starting in January 2020.
The company, which will be listed on the Nasdaq exchange under the ticker symbol "LVGO," offers tech-enabled solutions that help to monitor and manage people with chronic conditions like diabetes, hypertension and behavioral health issues.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A visit to the Louisiana health system sheds some light on how it is innovatively addressing chronic diseases like hypertension and diabetes, the inpatient experience and more.
Patients who also had another chronic disease, were using insulin daily to manage their Type 2 Diabetes or had lived with diabetes for more than two years were more likely to have a positive effect on empowerment measurements.
MedCity News caught up with Omron Healthcare CEO Ranndy Kellogg at the the AdvaMed Digital MedTech Conference in San Francisco to speak about the company's new products, emerging business lines and how collaboration with other companies have driven recent innovation.
In an interview, Livongo Chief Commercial Officer Jim Pursley discussed how the company has moved beyond its initial focus of diabetes management to other conditions that may overlap with the needs of its members, such as hypertension and its recent move into behavioral health.
Through the collaboration, Hello Heart will offer its customers LifeScan's OneTouch line of connected glucose monitors and test strips which can upload results automatically onto the company's platform.